A61K 31/195
Having an amino group
Official title: having an amino group
A61K31/195 (Having an amino group) appears on 8,891 US grants and 15,333 published applications in this corpus.
Search patents in A61K- Granted patents
- 8,891
- Published applications
- 15,333
- Assignees
- 5,274
- Inventors
- 22,531
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 23 | 0 |
| 1978 | 25 | 0 |
| 1979 | 27 | 0 |
| 1980 | 43 | 0 |
| 1981 | 20 | 0 |
| 1982 | 20 | 0 |
| 1983 | 25 | 0 |
| 1984 | 19 | 0 |
| 1985 | 19 | 0 |
| 1986 | 19 | 0 |
| 1987 | 26 | 0 |
| 1988 | 36 | 0 |
| 1989 | 37 | 0 |
| 1990 | 33 | 0 |
| 1991 | 35 | 0 |
| 1992 | 54 | 0 |
| 1993 | 59 | 0 |
| 1994 | 57 | 0 |
| 1995 | 75 | 0 |
| 1996 | 104 | 0 |
| 1997 | 165 | 0 |
| 1998 | 155 | 0 |
| 1999 | 176 | 0 |
| 2000 | 127 | 0 |
| 2001 | 164 | 59 |
| 2002 | 170 | 251 |
| 2003 | 164 | 420 |
| 2004 | 129 | 472 |
| 2005 | 112 | 488 |
| 2006 | 165 | 473 |
| 2007 | 130 | 444 |
| 2008 | 112 | 402 |
| 2009 | 105 | 462 |
| 2010 | 155 | 505 |
| 2011 | 168 | 495 |
| 2012 | 223 | 491 |
| 2013 | 326 | 600 |
| 2014 | 392 | 768 |
| 2015 | 381 | 772 |
| 2016 | 416 | 725 |
| 2017 | 475 | 760 |
| 2018 | 443 | 686 |
| 2019 | 471 | 762 |
| 2020 | 458 | 806 |
| 2021 | 445 | 876 |
| 2022 | 434 | 883 |
| 2023 | 401 | 795 |
| 2024 | 372 | 726 |
| 2025 | 390 | 642 |
| 2026 | 289 | 570 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Stable levothyroxine compositions in aprotic polar solvents6 Oct 2026US 12,751,937 B2Xeris Pharmaceuticals, Inc.
- Synergistic activity of novel compounds against planktonic and biofilm cells of clinically relevant pathogens6 Oct 2026US 12,752,038 B2SterileCare Inc.
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Compounds and formulations29 Sep 2026US 12,746,248 B2Pro-Al Medico-Technologies, Inc.
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Tea compositions comprising paraxanthine and methods of production thereof8 Oct 2026US 2026/0305643 A1
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Combination treatment for netherton syndrome8 Oct 2026US 2026/0306448 A1Quoin Pharmaceuticals, Inc.
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Tissue penetrating catheters having integral imaging transducers and their methods of use642US 6,375,615 B1TransVascular, Inc. · 2002
- Stabilized tissue penetrating catheters462US 6,726,677 B1TransVascular, Inc. · 2004